SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
3.790
+0.050 (1.34%)
At close: Feb 19, 2026, 4:00 PM EST
3.940
+0.150 (3.96%)
After-hours: Feb 19, 2026, 5:10 PM EST

SAB Biotherapeutics Market Cap

SAB Biotherapeutics has a market cap or net worth of $180.1 million as of February 19, 2026. Its market cap has increased by 807.61% in one year.

Market Cap
180.10M
Enterprise Value
73.36M
1-Year Change
807.61%
Ranking
Category
Stock Price
$3.79

Market Cap Chart

Since February 9, 2021, SAB Biotherapeutics's market cap has increased from $130.75M to $180.10M, an increase of 37.74%. That is a compound annual growth rate of 6.58%.

History

DateMarket Cap% Change
Feb 18, 2026178.05M-
Dec 31, 2025178.05M408.46%
Dec 31, 202435.02M-44.79%
Dec 29, 202363.43M113.36%
Dec 30, 202229.73M-91.24%
Dec 31, 2021339.54M159.68%
Feb 9, 2021 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition